In breast cancer tissues, the SEMA6B promoter undergoes abnormal methylation, and downregulation of SEMA6B messenger RNA (mRNA) has been found in tumor samples (D'Apice and Costa 2013; Kuznetsova et al., 2007). This evidence concerns the gene SEMA6B and neoplasm.